Red Ginseng's Potential as a Natural Treatment for Improving Withdrawal Symptoms and Dependency due to Drug Addiction Proven Scientifically
Comunicato Precedente
Comunicato Successivo
Prof. Oh's research team, through experiments on mice, confirmed that the experiment group consuming red ginseng showed a 50% reduction in leap behaviors indicating physical dependency compared to the control group during morphine administration. In the conditioned place preference test for evaluating psychological dependency, the red ginseng group scored about three times lower than the control group, significantly reducing psychological dependency caused by drug addiction.
In addition, the study revealed a link between red ginseng and detoxification in the liver. Glutathione in the liver, involved in detoxification, showed recovery in the red ginseng group, which had decreased due to morphine addiction, indicating an approximately 90% effectiveness compared to the control group.
The impact of red ginseng on improving liver function has been consistently studied. In October, at the academic conference of the Korean Society of Food Science and Nutrition held in Busan, significant research results on the improvement of non-alcoholic fatty liver disease by red ginseng were presented. Human trials with 94 patients confirmed that the consumption of red ginseng regulated gut microbiota, increasing beneficial bacteria and reducing harmful bacteria, thereby improving damaged livers.
This study scientifically proves the usefulness of red ginseng in treating drug addiction and confirms its potential as a natural treatment for substance dependency, marking an important milestone.
Photo - https://mma.prnewswire.com/media/2285307/Red_Ginseng_s_Potential_a_Natural_Treatment_Improving_Withdrawal_Symptoms_Dependency.jpg
View original content:https://www.prnewswire.co.uk/news-releases/red-ginsengs-potential-as-a-natural-treatment-for-improving-withdrawal-symptoms-and-dependency-due-to-drug-addiction-proven-scientifically-302000410.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
